Pillstats
Rx only · Film, Soluble · Buccal

Buprenorphine Hydrochloride, Naloxone Hydrochloride

Brands: Suboxone · Buprenorphine Hydrochloride + Naloxone Hydrochloride

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US4 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)1819
US makers1 labelers
Packages4
DEA / ScheduleCIII

US acquisition costNADAC · per unit

Average across 4 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$2.81$5.63$8.44$11.26Dec 2025Apr 2026Jul 2026
$9.785
Latest avg · Jul 22, 2026
-0%
Since Dec 17, 2025
1
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

342K683K1.0M1.4M2025 Q12025 Q22025 Q32025 Q42026 Q1
1.1M
Rx · 2026 Q1
40.8M
Units dispensed
-11%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Indivior Inc.unknown4SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.